Dr. Redjal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3 Cooper Plz
Rm 104
Camden, NJ 08103Phone+1 856-342-3159Fax+1 732-790-0107
Education & Training
- Massachusetts General HospitalResidency, Neurological Surgery, 2008 - 2015
- Massachusetts General HospitalInternship, Surgery, 2008 - 2009
- Harvard Medical SchoolClass of 2008
Certifications & Licensure
- CA State Medical License 2015 - 2025
- NJ State Medical License 2017 - 2025
- PA State Medical License 2020 - 2022
- American Board of Neurological Surgery Neurological Surgery
Clinical Trials
- Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery Start of enrollment: 2017 Jun 14
- 3D Prediction of Patient-Specific Response Start of enrollment: 2018 Jun 11
- A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden Start of enrollment: 2020 Dec 24
Publications & Presentations
PubMed
- 42 citationsValproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/I...Navid Redjal, Clemens Reinshagen, Andrew Q. Le, Brian P. Walcott, Erin McDonnell
Journal of Neuro-Oncology. 2016-02-01 - 30 citationsPre-clinical tumor models of primary brain tumors: Challenges and opportunitiesFarhana Akter, Brennan Simon, Nadine Leonie de Boer, Navid Redjal, Hiroaki Wakimoto
Biochimica Et Biophysica Acta. Reviews on Cancer. 2021-01-01 - 282 citationsTreatment for Brain Metastases: ASCO-SNO-ASTRO Guideline.Michael A Vogelbaum, Paul D Brown, Hans Messersmith, Priscilla K Brastianos, Stuart Burri
Journal of Clinical Oncology. 2022-02-10
Press Mentions
- Center for Neuro-Oncology Leads New Brain Tumor Guidelines Paper and Advances Participation in Immunotherapy Trials for Glioblastoma PatientsApril 6th, 2021
- KIYATEC Announces Addition of Capital Health as Clinical Site in Trial to Predict GBM Patient-Specific Response to Cancer Drugs Prior to TreatmentAugust 13th, 2019
- Center for Neuro-Oncology Leads New Brain Tumor Guidelines Paper and Advances Participation in Immunotherapy Trials for Glioblastoma PatientsApril 8th, 2021
- Join now to see all
Professional Memberships
- Member
- Fellow
- Society of Neuro-oncologyMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: